Principal Investigator
Macarena De La Fuente
Enrollment Status
Not Accepting
Clinical Trial ID
Institutional Protocol #
20231209
Clinical Trial Summary
A Phase 2 Study of Erdafitinib in Patients with Recurrent or Progressive IDH-Wild Type Glioma with an FGFR-TACC Gene Fusion
Phase
Phase II
Funding Agency/Sponsor
National Cooperative Group
Disease
Neurological Cancer
Contact Information
Phone Number
+1 (305) 2437261